iTeos Therapeutics, Inc.
ITOS
$7.77
$0.273.60%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.32% | -19.33% | -96.72% | -280.66% | -1,274.64% |
| Total Depreciation and Amortization | 28.37% | 37.86% | 27.85% | 21.71% | 15.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -7.12% | -2.62% | 30.92% | 11.14% | -1.36% |
| Change in Net Operating Assets | 103.37% | 311.92% | 74.85% | 74.58% | 104.40% |
| Cash from Operations | 9.18% | 5.37% | -0.24% | -0.90% | 3.64% |
| Capital Expenditure | 79.19% | 44.94% | -70.54% | -246.81% | -356.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -133.91% | -271.27% | 81.42% | 107.57% | 108.09% |
| Cash from Investing | -139.88% | -280.50% | 80.83% | 106.78% | 107.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 21,933.75% | 10,925.88% | 10,850.13% | 10,945.45% | -52.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -146.08% | -- | -- |
| Cash from Financing | 21,848.11% | 10,883.02% | 5,508.39% | 5,557.68% | -75.01% |
| Foreign Exchange rate Adjustments | 124.70% | 46.42% | -309.42% | 40.55% | 54.95% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 112.62% | -224.59% | 85.34% | 106.07% | 86.86% |